Mode
Text Size
Log in / Sign up
N/A N=162

KBTH-GIRHL Healthy Birth Weight Study: A Cross-Section

Infant, Small for Gestational Age · Infant, Low Birth Weight · Pregnancy · Sleep · Infant, Very Low Birth Weight

Enrolled (actual)
162
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcome: Primary: Birth Weight of Baby — 3033 grams

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Age
Adult · 18+ yrs
Sex
Female
Sponsor
IWK Health Centre
Primary completion
Feb 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Birth Weight of Baby
3033
PRIMARY
Customized Birth Weight Centile
46.0
SECONDARY
Gestational Age at Delivery
38.3
SECONDARY
Small for Gestational Age
25
SECONDARY
Low Birth Weight
21
SECONDARY
Sex of Newborn
82; 80
SECONDARY
Preterm Delivery
42
SECONDARY
Mode of Delivery
122; 40; 0

Summary

This study was designed and conducted in an effort to establish a comparison group for the Ghana PrenaBelt Trial (NTC02379728). The Ghana PrenaBelt Trial examined the effect, on birth weight, of a belt-like device to help pregnant women to avoid sleeping on their back during sleep in the third trimester. This study will seek to establish the typical birth weight of babies born to a cohort of healthy pregnant Ghanian women who are similar in characteristics to the women in the Ghana PrenaBelt Trial but who have not been educated to avoid back sleep during pregnancy nor have received a device to prevent back sleep.

Eligibility Criteria

Inclusion Criteria

  • Low-risk singleton pregnancy
  • *Delivered a live birth >28 weeks gestation at KBTH within the past 48 hours.
  • Residing in the Greater Accra Metropolitan Area or area served by the KBTH.
  • Fluent in either English, Twi, or Ga
  • **Has not received education/ information about back sleep position in pregnancy as a potential risk factor for stillbirth and low birth weight.

Exclusion Criteria

  • BMI ≥ 35 at booking (first antenatal appointment for current pregnancy)
  • Pregnancy complicated by obstetric complications (hypertension [pre-eclampsia, gestational hypertension, chronic hypertension], diabetes [gestational or not], or intra-uterine growth restriction [ 35
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03062228). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search